Literature DB >> 31733067

Cumulative evidence for the relationship between body mass index and the risk of esophageal cancer: An updated meta-analysis with evidence from 25 observational studies.

Jie Tian1, Chunjian Zuo1, Guanchu Liu1, Pengyu Che2, Gang Li3, Xiang Li4, Huanwen Chen1.   

Abstract

BACKGROUND AND AIM: A large number of papers reporting the relationships between body mass index (BMI) and esophageal cancer (EC) risk have been published in the past few decades; however, these results are inconsistent. Therefore, we carried out meta-analyses to explore the relationships between BMI and the risk of EC (including esophageal squamous cell carcinoma [ESCC] and esophageal adenocarcinoma [EADC]).
METHODS: We used the Web of Science, PubMed, and Embase to identify all published/online articles before December 30, 2018, which yielded 25 articles eligible for data extraction (including 16,561 cases and 11,954,161 controls), and then pooled the relative risks (RRs) and corresponding 95% confidence intervals (CIs) using random-effects model.
RESULTS: Our study presented that underweight had statistically significant association with the risk of EC (RR = 1.78, 95% CI = 1.48, 2.14, P < 0.001) and ESCC (RR = 1.57, 95% CI = 1.20, 2.06, P = 0.001) when compared with normal weight. Interestingly, both overweight and obesity could increase the risk of EADC (RR = 1.56, 95% CI = 1.42, 1.71, P < 0.001; RR = 2.34, 95% CI = 2.02, 2.70, P < 0.001) while decrease the risk of ESCC (RR = 0.71, 95% CI = 0.60, 0.84, P < 0.001; RR = 0.63, 95% CI = 0.60, 0.84, P = 0.002). Additionally, obesity could increase the risk of EC (RR = 1.51, 95% CI = 1.21, 1.89, P < 0.001).
CONCLUSION: These meta-analyses provide a comprehensive and updated epidemiological evidence to confirm the associations between BMI and EC risk. These findings have public health implications with respect to better control bodyweight and then reduce the occurrence of EC (including ESCC and EADC).
© 2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  body mass index; esophageal cancer; meta-analysis; observational studies

Year:  2019        PMID: 31733067     DOI: 10.1111/jgh.14917

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

1.  Intracellular Nampt impairs esophageal squamous cell carcinoma neo-adjuvant chemotherapy response independent of eNampt.

Authors:  Jiahuang Liu; Xiangming Che; Jiangtao You; Guangjian Zhang; Rui Zhao; Junke Fu; Haijun Li
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Association between body mass index and oesophageal cancer mortality: a pooled analysis of prospective cohort studies with >800 000 individuals in the Asia Cohort Consortium.

Authors:  Sangjun Lee; Jieun Jang; Sarah Krull Abe; Shafiur Rahman; Eiko Saito; Rashedul Islam; Prakash C Gupta; Norie Sawada; Akiko Tamakoshi; Xiao-Ou Shu; Woon-Puay Koh; Atsuko Sadakane; Ichiro Tsuji; Jeongseon Kim; Isao Oze; Chisato Nagata; San-Lin You; Myung-Hee Shin; Mangesh S Pednekar; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Wanqing Wen; Kotaro Ozasa; Sanae Matsuyama; Seiki Kanemura; Aesun Shin; Hidemi Ito; Keiko Wada; Yumi Sugawara; Chien-Jen Chen; Yoon-Ok Ahn; Yu Chen; Habibul Ahsan; Paolo Boffetta; Kee Seng Chia; Keitaro Matsuo; You-Lin Qiao; Nathaniel Rothman; Wei Zheng; Manami Inoue; Daehee Kang; Sue K Park
Journal:  Int J Epidemiol       Date:  2022-08-10       Impact factor: 9.685

3.  Association of Metabolic Parameter Variability with Esophageal Cancer Risk: A Nationwide Population-Based Study.

Authors:  Ji Eun Lee; Kyungdo Han; Juhwan Yoo; Yohwan Yeo; In Young Cho; Belong Cho; Hyuktae Kwon; Dong Wook Shin; Jong Ho Cho; Yong-Moon Park
Journal:  J Pers Med       Date:  2022-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.